XML 24 R13.htm IDEA: XBRL DOCUMENT v3.8.0.1
OTHER CURRENT LIABILITIES
9 Months Ended
Sep. 30, 2017
Other Liabilities Disclosure [Abstract]  
OTHER CURRENT LIABILITIES

NOTE 8 – OTHER CURRENT LIABILITIES

 

Other current liabilities consist of the following:

 

   

September 30,

2017

   

December 31,

2016

 
Accrued clinical trial costs   $ 556,048     $ 1,281,080  
Accrued payroll, bonuses and commission costs     2,662,359       3,531,440  
Accrued compensated absences     952,587       665,561  
Accrued legal and accounting expense     366,828       176,518  
Accrued sales and marketing costs     69,041       665,773  
Other accrued expenses     319,015       224,865  
Allowance for wholesale distributor fees     145,563       76,510  
Accrued royalties     93,870       26,507  
Allowance for coupons and returns     1,218,249       794,816  
Accrued rent     293,672       181,015  
TOTAL OTHER CURRENT LIABILITIES   $ 6,677,232     $ 7,624,085